Clinical Trial Update: Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating nivolumab as neoadjuvant and adjuvant therapy for hepatocellular carcinoma treated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• OPDIVO (nivolumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED